An investigation on behalf of investors in Windtree Therapeutics, Inc. (OTC: WINT) shares over potential wrongdoing at Windtree Therapeutics, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 01/07/2019 -- An investigation was announced for investors in shares of Windtree Therapeutics, Inc. (OTC: WINT) over potential breaches of fiduciary duties by certain officers and directors at Windtree Therapeutics.
Investors who purchased shares of Windtree Therapeutics, Inc. (OTC: WINT) and currently hold any of those OTC: WINT shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Windtree Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Warrington, PA based Windtree Therapeutics, Inc., a biotechnology company, focuses on developing surfactant therapies for respiratory diseases and other potential applications. Windtree Therapeutics, Inc. reported that its annual Total Revenue declined from $2.04 million in 2016 to $1.48 million in 2017 and that its Net Loss declined from $39.49 million in 2016 to $18.44 million in 2017.
Shares of Windtree Therapeutics, Inc. (OTC: WINT) declined from $66.00 per share in October 2016 to as low as $2.53 per share in October 2018.
Those who purchased shares of Windtree Therapeutics, Inc. (OTC: WINT), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels